Residents of North Carolina who have high blood pressure should be aware that medications to treat the condition were recalled. The action was taken because of potentially high carcinogenic levels in the drugs. What medications were recalled? Two types of blood...
In 2018 the FDA initiated a recall of the generic blood pressure medication Valsartan after it was discovered that many lots of the drug were contaminated with the cancer-causing substance N-Nitrosodimethylamine (NDMA). NDMA is a byproduct of a chemical reaction that...
While surgical mesh has been used for years to implement repairs, offer support and promote healing, there are numerous reasons why some meshes that are currently in use have a propensity to cause pain, infection and even fail—ultimately requiring corrective/revision...
For years, has been investigating early failure of total knee replacements after receiving many inquiries from injured people. Recent studies indicate that the problem may not be with the hardware, but with the bone cement used to secure...
On the U.S. market since 2006, Allergan's BIOCELL textured breast implants have been linked to a severely increased risk of breast implant-related anaplastic large cell lymphoma (BIA-ALCL). Other implants on the market with smooth surfaces do not carry the same risks....
If you are experiencing pain or suffering from a defective medical device, it’s wise to consult an attorney. For answers about legal issues in this article or with your own malfunctioning medical product, call me directly for help – Lawrence Egerton, 336-814-2126, or…
This important Social Security press release is copied here in its entirety: “Supplemental Security Income (SSI) recipients who don’t file tax returns will start receiving their automatic Economic Impact Payments directly from the Treasury Department in early May....
The U.S. Food and Drug Administration (FDA) announced yesterday that it is requesting that manufacturers withdraw all prescription (Rx) and over-the-counter (OTC) ranitidine drugs (commonly known by the brand name Zantac) from the market immediately. This is the...
On July 24, 2019, medical device manufacturer Allergan recalled dozens of models of textured breast implants. The implants have been associated with an increased risk of breast implant-associated anapestic large cell lymphoma (“BIA-ALCL”). Allergan introduced the...
In an order issued Monday, August 5, 2019, Judge Catherine Blake ruled that claims against medical device manufacturer Smith & Nephew will continue in litigation in the Maryland Federal Court. Lawsuits against Smith & Nephew for injuries allegedly caused by...
